Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
Uterine cervical and endometrial cancers are the two most common gynecological malignancies. As demonstrated in other types of solid malignancies, an increased number of circulating or tumor-infiltrating myeloid-derived suppressor cells (MDSCs) have also been observed in uterine cervical and endomet...
Main Authors: | Seiji Mabuchi, Tomoyuki Sasano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1073 |
Similar Items
-
Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
by: Seiji Mabuchi, et al.
Published: (2021-02-01) -
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
by: Yajing Mi, et al.
Published: (2020-04-01) -
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
by: Amir A. Al-Khami, et al.
Published: (2017-10-01) -
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells
by: Calogero eVetro, et al.
Published: (2015-05-01) -
The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations
by: Eriko Yokoi, et al.
Published: (2019-12-01)